IRIS

A randomized, double-blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin II receptor blockers in hypertensive type 2 diabetic patients

Derosa, Giuseppe
;D’angelo, Angela
Membro del Collaboration Group
;Maffioli, Pamela
Membro del Collaboration Group
2018-01-01
2018
Cardiovascular & Hematology Research covers all levels of investigation into the normal and pathogenic functions of the heart, vasculature, and soluble blood components. Cell biology of vascular tissue and formed elements of blood, biochemical regulation of thrombosis, therapeutic strategies for treatment of cardiac and vascular diseases are also considered. Resources on hematologic oncology are excluded and are placed in the Oncogenesis & Cancer Research category.
DRUG DESIGN, DEVELOPMENT AND THERAPY
sì
2-s2.0-85057806579
Esperti anonimi
Inglese
Internazionale
ELETTRONICO
12
2611
2616
6
30197501
Canrenone; Hydrochlorothiazide; Metabolism; Type 2 diabetes mellitus; Angiotensin Receptor Antagonists; Antihypertensive Agents; Canrenone; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Male; Middle Aged; Pharmacology; 3003; Drug Discovery3003 Pharmaceutical Science
https://www.dovepress.com/getfile.php?fileID=43893
no
5
info:eu-repo/semantics/article
262
Derosa, Giuseppe; Gaudio, Giovanni; Pasini, Gianfranco; D’Angelo, Angela; Maffioli, Pamela
1 Contributo su Rivista::1.1 Articolo in rivista
none
1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/1229326
Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 9
  • ???jsp.display-item.citation.isi??? ND
social impact